(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
@ $12.38
Issued: 9 Feb 2024 @ 14:43
Return: 13.81%
Previous signal: Feb 7 - 15:52
Previous signal:
Return: -1.59 %
Live Chart Being Loaded With Signals
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases...
Stats | |
---|---|
Today's Volume | 29 386.00 |
Average Volume | 66 987.00 |
Market Cap | 886.51M |
Next earnings date | ( $0 ) 2024-05-30 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.82 |
ATR14 | $0.172 (1.23%) |
Volume Correlation
Abivax SA American Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Abivax SA American Correlation - Currency/Commodity
Abivax SA American Financials
Annual | 2023 |
Revenue: | $4.62M |
Gross Profit: | $3.91M (84.70 %) |
EPS: | $-3.43 |
FY | 2023 |
Revenue: | $4.62M |
Gross Profit: | $3.91M (84.70 %) |
EPS: | $-3.43 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-110 000 (0.00 %) |
EPS: | $-3.13 |
Financial Reports:
No articles found.
Abivax SA American
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators